149 related articles for article (PubMed ID: 26050350)
1. Pelvic exenteration--our initial experience in 15 cases.
Căpîlna ME; Moldovan B; Szabo B
Eur J Gynaecol Oncol; 2015; 36(2):142-5. PubMed ID: 26050350
[TBL] [Abstract][Full Text] [Related]
2. Pelvic exenteration for primary and recurrent gynaecological malignancies.
de Wilt JH; van Leeuwen DH; Logmans A; Verhoef C; Kirkels WJ; Vermaas M; Ansink AC
Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):243-8. PubMed ID: 16950559
[TBL] [Abstract][Full Text] [Related]
3. Pelvic exenteration for gynecologic malignancies: Postoperative complications and oncologic outcomes.
Romeo A; Gonzalez MI; Jaunarena J; Zubieta ME; Favre G; Tejerizo JC
Actas Urol Esp (Engl Ed); 2018 Mar; 42(2):121-125. PubMed ID: 28911880
[TBL] [Abstract][Full Text] [Related]
4. Comparation between the Bricker ileal conduit vs double-barrelled wet colostomy after pelvic exenteration for gynaecological malignancies.
Lago V; Pradillo Aramendi T; Segarra-Vidal B; Padilla-Iserte P; Matute L; Gurrea M; Pontones JL; Delgado F; Domingo S
Eur J Obstet Gynecol Reprod Biol; 2023 Mar; 282():140-145. PubMed ID: 36716537
[TBL] [Abstract][Full Text] [Related]
5. [Pelvic exenteration of advanced gynecological malignacies: a report of 18 cases].
Zhang Z; Zang R; Chen J
Zhonghua Fu Chan Ke Za Zhi; 2000 May; 35(5):288-90. PubMed ID: 11775910
[TBL] [Abstract][Full Text] [Related]
6. Major complications of urinary diversion after pelvic exenteration for gynecologic malignancies: a 23-year mono-institutional experience in 124 patients.
Houvenaeghel G; Moutardier V; Karsenty G; Bladou F; Lelong B; Buttarelli M; Delpero JR
Gynecol Oncol; 2004 Feb; 92(2):680-3. PubMed ID: 14766266
[TBL] [Abstract][Full Text] [Related]
7. Choices in creating continent urostomies following pelvic exenteration for gynecologic malignancies.
Silver DF; Ashwell TR
Gynecol Oncol; 2001 Sep; 82(3):510-5. PubMed ID: 11520148
[TBL] [Abstract][Full Text] [Related]
8. Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA.
Berek JS; Howe C; Lagasse LD; Hacker NF
Gynecol Oncol; 2005 Oct; 99(1):153-9. PubMed ID: 16054678
[TBL] [Abstract][Full Text] [Related]
9. Urological leaks after pelvic exenterations comparing formation of colonic and ileal conduits.
Teixeira SC; Ferenschild FT; Solomon MJ; Rodwell L; Harrison JD; Young JM; Vasilaras A; Eisinger D; Lee P; Byrne C
Eur J Surg Oncol; 2012 Apr; 38(4):361-6. PubMed ID: 22265840
[TBL] [Abstract][Full Text] [Related]
10. [Pelvic exenterations for gynaecological cancer--a 10 year institutional review].
Pinelo S; Petiz A; Domingues C; Lopes C; Alves A; Fael R
Acta Med Port; 2006; 19(2):99-104. PubMed ID: 17187709
[TBL] [Abstract][Full Text] [Related]
11. A modern-day experience with Brunschwig's operation: Outcomes associated with pelvic exenteration.
Rios-Doria E; Filippova OT; Straubhar AM; Chi A; Awowole I; Sandhu J; Broach V; Mueller JJ; Gardner GJ; Jewell EL; Zivanovic O; Leitao MM; Long Roche K; Abu-Rustum NR; Sonoda Y
Gynecol Oncol; 2022 Nov; 167(2):277-282. PubMed ID: 36064678
[TBL] [Abstract][Full Text] [Related]
12. Pelvic exenterations for gynecological malignancies: a study of 36 cases.
Kaur M; Joniau S; D'Hoore A; Van Calster B; Van Limbergen E; Leunen K; Penninckx F; Van Poppel H; Amant F; Vergote I
Int J Gynecol Cancer; 2012 Jun; 22(5):889-96. PubMed ID: 22617477
[TBL] [Abstract][Full Text] [Related]
13. Pelvic exenteration for gynecologic malignancies: The experience of a tertiary center from Greece.
Haidopoulos D; Pergialiotis V; Aggelou K; Thomakos N; Alexakis N; Stamatakis E; Rodolakis A
Surg Oncol; 2022 Mar; 40():101702. PubMed ID: 35065392
[TBL] [Abstract][Full Text] [Related]
14. Pelvic exenteration for recurrent gynecologic malignancy: a study of 28 consecutive patients at a single institution.
Jäger L; Nilsson PJ; Rådestad AF
Int J Gynecol Cancer; 2013 May; 23(4):755-62. PubMed ID: 23407096
[TBL] [Abstract][Full Text] [Related]
15. Colorectal function preservation in posterior and total supralevator exenteration for gynecologic malignancies: an 89-patient series.
Moutardier V; Houvenaeghel G; Lelong B; Mokart D; Delpero JR
Gynecol Oncol; 2003 Apr; 89(1):155-9. PubMed ID: 12694670
[TBL] [Abstract][Full Text] [Related]
16. [Initial experience in exenteration interventions in the pelvis].
Cibula D; Svárovský J; Ungár L; Babjuk M; Pesková M; Gürlich R; Zivný J; Freitag P; Dundr P; Mares P
Ceska Gynekol; 2004 Nov; 69(6):483-8. PubMed ID: 15633419
[TBL] [Abstract][Full Text] [Related]
17. Comparison of postoperative complications and quality of life between patients undergoing continent versus non-continent urinary diversion after pelvic exenteration for gynecologic malignancies.
Angeles MA; Mallet E; Rouanet P; Cabarrou B; Méeus P; Lambaudie E; Foucher F; Narducci F; Loaec C; Gouy S; Guyon F; Marchal F; Gladieff L; Martínez-Gómez C; Migliorelli F; Martinez A; Ferron G
Int J Gynecol Cancer; 2020 Feb; 30(2):233-240. PubMed ID: 31796531
[TBL] [Abstract][Full Text] [Related]
18. Pelvic Exenteration in Gynecologic Cancer: La Paz University Hospital Experience.
Moreno-Palacios E; Diestro MD; De Santiago J; Hernández A; Zapardiel I
Int J Gynecol Cancer; 2015 Jul; 25(6):1109-14. PubMed ID: 25853383
[TBL] [Abstract][Full Text] [Related]
19. Performance and outcome of pelvic exenteration for gynecologic malignancies: A population-based study.
Matsuo K; Mandelbaum RS; Adams CL; Roman LD; Wright JD
Gynecol Oncol; 2019 May; 153(2):368-375. PubMed ID: 30792003
[TBL] [Abstract][Full Text] [Related]
20. Robotic or laparoscopic pelvic exenteration for gynecological malignancies: feasible options to open surgery.
Dudus L; Minciuna C; Tudor S; Lacatus M; Stefan B; Vasilescu C
J Gynecol Oncol; 2024 Mar; 35(2):e12. PubMed ID: 37921597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]